Blockade of IL-6 signal exacerbates acute inflammatory bowel disease via inhibiting IL-17 producing in activated CD4+ Th17 population.

MLA

S.-J. Zhang, et al. “Blockade of IL-6 Signal Exacerbates Acute Inflammatory Bowel Disease via Inhibiting IL-17 Producing in Activated CD4+ Th17 Population.” European Review for Medical & Pharmacological Sciences, vol. 17, no. 24, Dec. 2013, pp. 3291–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=93387426&authtype=sso&custid=ns315887.

APA

S.-J. Zhang, L. Wang, L. Ming, X.-B. Guo, H.-M. Wang, X.-W. Li, & L. Li. (2013). Blockade of IL-6 signal exacerbates acute inflammatory bowel disease via inhibiting IL-17 producing in activated CD4+ Th17 population. European Review for Medical & Pharmacological Sciences, 17(24), 3291–3295.

Chicago

S.-J. Zhang, L. Wang, L. Ming, X.-B. Guo, H.-M. Wang, X.-W. Li, and L. Li. 2013. “Blockade of IL-6 Signal Exacerbates Acute Inflammatory Bowel Disease via Inhibiting IL-17 Producing in Activated CD4+ Th17 Population.” European Review for Medical & Pharmacological Sciences 17 (24): 3291–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=93387426&authtype=sso&custid=ns315887.